Tuesday, March 27, 2012

Reuters: Financial Services and Real Estate: Swiss stocks - Factors to watch on March 28

Reuters: Financial Services and Real Estate
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com
Swiss stocks - Factors to watch on March 28
Mar 28th 2012, 05:37

ZURICH, March 28 | Wed Mar 28, 2012 1:37am EDT

ZURICH, March 28 (Reuters) - The following are some of the main factors expected to affect Swiss stocks on Wednesday:

UBS

Germany's HSH Nordbank AG may not pursue a fraud case against UBS AG over a soured $500 million mortgage investment, a New York appeals court ruled on Tuesday, reversing a lower court.

For more, click on:

PETROPLUS

Insolvent oil refiner Petroplus said on Wednesday it planned to negotiate a sale of its assets and would delist its shares from the Swiss bourse by mid-May after it was pushed into bankruptcy earlier this year.

For more, click on:

COMPANY STATEMENTS

* A study in the Journal of American Medial Association showed significant survival benefit in certain GIST patients taking Novartis drug Glivec for three years after surgery.

* Sonova said it is introducing new Lyric hearing aids, which can be worn for up to four months without removing the device or changing batteries.

* Bobst said it swung to a full-year net profit from a loss on cost cuts despite a slip in sales, and that it will turn to growth markets to counter the strong Swiss franc.

* Looser said full-year net profit rose to 27.7 million Swiss francs from 24 million francs year-ago amid disposal gains, and that it will pay shareholders 1.70 francs a share.

* SHL said fourth-quarter profit fell to $300,000 from $900,000 amid a 30 percent drop in revenue, and flagged lower earnings this year as revenue from Philips U.S. falls away.

* Cosmo Pharmaceuticals said it will propose Mauro Ajani as chairman to replace Rolf Stahel, who will not stand for reelection, and also add Prof. Dr. Maria Grazia Roncarolo as an independent director.

* National said full-year net profit rose 82 percent to 167.7 million Swiss francs, including a one-off reserve release of 67.1 million francs and an after-tax transaction profit of 6.1 million francs from selling its group life insurance business.

* Valora said full-year net profit fell to 57.4 million Swiss francs from 63.6 million francs, and proposed an unchanged dividend of 11.50 francs per share.

ECONOMY

FOR COMPANIES TRADING EX-DIVIDEND, PLEASE CLICK ON:

for all Swiss stocks

for blue chips

for other stocks

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

 
Great HTML Templates from easytemplates.com.